Using Mitra sampling to support first-in-human pharmacokinetic evaluations for PF-07059013

Bioanalysis. 2023 Sep;15(17):1083-1094. doi: 10.4155/bio-2023-0066. Epub 2023 Aug 16.

Abstract

Aim: A sensitive and selective method for the determination of PF-07059013 in dried blood collected by Mitra™ tips was developed and qualified from 50 to 50,000 ng/ml. Materials & methods: PF-07059013 is isolated from 10 μl of human dried blood by extraction with methanol and analyzed by HPLC-MS/MS. Results & conclusions: In addition to routine validation elements, impact of hematocrit and Mitra tip's lot-to-lot variation on assay accuracy were evaluated. The qualified method was used in one clinical study with excellent performance. Correlation coefficient between blood concentrations obtained from liquid-incurred blood samples and dried-incurred blood samples is 0.95. Clinical Trial Registration: NCT04323124 (ClinicalTrials.gov).

Keywords: LC–MS/MS; Mitra; assay concordance; dried blood; microsampling; qualification.

Publication types

  • Review

MeSH terms

  • Chromatography, High Pressure Liquid / methods
  • Dried Blood Spot Testing* / methods
  • Hematocrit
  • Humans
  • Specimen Handling
  • Tandem Mass Spectrometry* / methods

Associated data

  • ClinicalTrials.gov/NCT04323124

Grants and funding